ATXI insider transaction filings
AVENUE THERAPEUTICS, INC. — 14 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-01-06. Screen ATXI transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for ATXI between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — AVENUE THERAPEUTICS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-06 | 4 | Fortress Biotech, Inc. — 10% owner | Grant/award (A): 111,209 @ $0 | EDGAR |
| 2025-04-02 | 4 | Fortress Biotech, Inc. — 10% owner | Grant/award (A): 33,724 @ $0 | EDGAR |
| 2024-12-03 | 4 | Herskowitz Neil — Director | Sale (S): 23 @ $2 | EDGAR |
| 2024-11-07 | 4 | KRANZLER JAY D — Director | Sale (S): 61 @ $2.24 | EDGAR |
| 2024-10-01 | 4 | KRANZLER JAY D — Director | Purchase (P): 3 @ $2.40 · Purchase (P): 497 @ $2.50 | EDGAR |
| 2024-09-25 | 4 | Jin David — Interim PFO and COO | Grant/award (A): 65,000 @ $0 | EDGAR |
| 2024-09-25 | 4 | ROSENWALD LINDSAY A MD — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-09-25 | 4 | Oltmans Curtis Gale — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-09-25 | 4 | MacLean Alexandra — Chief Executive Officer, Director | Grant/award (A): 170,000 @ $0 | EDGAR |
| 2024-09-25 | 4 | Charles Faith L. — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-09-25 | 4 | Herskowitz Neil — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-09-25 | 4 | KRANZLER JAY D — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-04-17 | 4 | Fortress Biotech, Inc. — 10% owner | Grant/award (A): 413,507 @ $0 | EDGAR |
| 2024-01-03 | 4 | Fortress Biotech, Inc. — 10% owner | Grant/award (A): 2,101,496 @ $0 | EDGAR |
Recent 8-K events — AVENUE THERAPEUTICS, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-02-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-31 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-11-18 | 8-K | ? 8.01 — Other Events | EDGAR |
| 2025-11-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-04-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-17 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-03-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-29 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-11-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-09-27 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ATXI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →